ECL - Ecolab Inc.
NYSE
->
Basic Materials
->
Specialty Chemicals
Saint Paul,
United States
Type: Equity
ECL price evolution
ECL
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $384 | $479.9 | $919.5 | |
| Short term investments | ||||
| Net receivables | $3031 | $2876.3 | $2786.6 | $2834.2 |
| Inventory | $1572.4 | $1505.9 | $1565.9 | $1497.2 |
| Total current assets | $6118.3 | $5752.3 | $5211.7 | $5644.1 |
| Long term investments | ||||
| Property, plant & equipment | $4233.7 | $3989.9 | $4017.4 | $4028.1 |
| Goodwill & intangible assets | $11155.9 | $11525 | $11641.7 | |
| Total noncurrent assets | $15709.5 | $16086.8 | $16202.5 | |
| Total investments | ||||
| Total assets | $22101.6 | $21461.8 | $21298.5 | $21846.6 |
| Current liabilities | ||||
| Accounts payable | $1812.3 | $1690.7 | $1607.1 | $1566.3 |
| Deferred revenue | ||||
| Short long term debt | $5.9 | $11.3 | $630.4 | |
| Total current liabilities | $4709.1 | $3847.6 | $3701.1 | $4345.8 |
| Long term debt | $6974.5 | $7977.4 | $7962.6 | $7976.9 |
| Total noncurrent liabilities | $9306.3 | $9371.8 | $9428.6 | |
| Total debt | $7983.3 | $7973.9 | $8607.3 | |
| Total liabilities | $13553.8 | $13153.9 | $13072.9 | $13774.4 |
| Shareholders' equity | ||||
| Retained earnings | $11228.4 | $10653.3 | $10324.5 | $10075.4 |
| Other shareholder equity | -$1853.8 | -$1899.4 | -$1881.2 | -$1850.4 |
| Total shareholder equity | $8287.4 | $8205.6 | $8044.7 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $919.5 | $598.6 | $359.9 | $1260.2 |
| Short term investments | ||||
| Net receivables | $2834.2 | $2698.1 | $2478.4 | $2273.8 |
| Inventory | $1497.2 | $1792.8 | $1491.8 | $1285.2 |
| Total current assets | $5644.1 | $5494.2 | $4687.1 | $5117.4 |
| Long term investments | ||||
| Property, plant & equipment | $4028.1 | $3741.6 | $3685.3 | $3548.7 |
| Goodwill & intangible assets | $11641.7 | $11693.4 | $12288 | $8983.9 |
| Total noncurrent assets | $16202.5 | $15970.1 | $16519.3 | $13008.6 |
| Total investments | ||||
| Total assets | $21846.6 | $21464.3 | $21206.4 | $18126 |
| Current liabilities | ||||
| Accounts payable | $1566.3 | $1728.2 | $1384.2 | $1160.6 |
| Deferred revenue | ||||
| Short long term debt | $630.4 | $505.1 | $411 | $17.3 |
| Total current liabilities | $4345.8 | $4210.4 | $3553.2 | $2932.2 |
| Long term debt | $7976.9 | $8075.3 | $8629.8 | $6969.8 |
| Total noncurrent liabilities | $9428.6 | $9995.3 | $10400.1 | $8992.3 |
| Total debt | $8607.3 | $8918.2 | $9040.8 | $6987.1 |
| Total liabilities | $13774.4 | $14228.2 | $13953.3 | $11924.5 |
| Shareholders' equity | ||||
| Retained earnings | $10075.4 | $9318.8 | $8814.5 | $8243 |
| Other shareholder equity | -$1850.4 | -$1726.6 | -$1634.8 | -$1994.4 |
| Total shareholder equity | $8044.7 | $7236.1 | $7224.2 | $6166.5 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3998.5 | $3751.9 | $3938.4 | |
| Cost of revenue | $2128.1 | $2284.4 | ||
| Gross Profit | $1737.9 | $1623.8 | $1654 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1077.7 | $1034.8 | ||
| Total operating expenses | $1024.8 | $1105.9 | $1064 | |
| Operating income | $517.9 | $590 | ||
| Income from continuing operations | ||||
| EBIT | $526 | $602.3 | ||
| Income tax expense | $246.5 | $42.3 | $126.7 | |
| Interest expense | -$70.4 | $71.6 | $70.4 | |
| Net income | ||||
| Net income | $736.5 | $412.1 | $405.2 | |
| Income (for common shares) | $412.1 | $405.2 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $15320.2 | $14187.8 | $12733.1 | $11790.2 |
| Cost of revenue | $9154.9 | $8831 | $7615.8 | $6905.8 |
| Gross Profit | $6165.3 | $5356.8 | $5117.3 | $4884.4 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $4061.6 | $3653.8 | $3416.1 | $3309.1 |
| Total operating expenses | $4173 | $3794.3 | $3518.7 | $3488.7 |
| Operating income | $1992.3 | $1562.5 | $1598.6 | $1395.7 |
| Income from continuing operations | ||||
| EBIT | $2031.5 | $1569.8 | $1618.4 | -$738.3 |
| Income tax expense | $362.5 | $234.5 | $270.2 | $176.6 |
| Interest expense | $296.7 | $243.6 | $218.3 | $290.2 |
| Net income | ||||
| Net income | $1372.3 | $1091.7 | $1129.9 | -$1205.1 |
| Income (for common shares) | $1372.3 | $1091.7 | $1129.9 | -$1205.1 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $490.9 | $412.1 | $405.2 | |
| Operating activities | ||||
| Depreciation | $235 | $234.8 | $230.5 | |
| Business acquisitions & disposals | -$38.7 | -$73.6 | ||
| Stock-based compensation | $35.9 | $47 | $21.7 | |
| Total cash flows from operations | $611.1 | $649.4 | $852.5 | |
| Investing activities | ||||
| Capital expenditures | -$194.1 | -$200.8 | -$262.2 | |
| Investments | ||||
| Total cash flows from investing | $193.7 | -$244.4 | -$201 | -$348.4 |
| Financing activities | ||||
| Dividends paid | -$502.9 | -$165.5 | -$175.2 | -$154.7 |
| Sale and purchase of stock | -$323 | -$196.4 | -$2 | |
| Net borrowings | -$5.5 | -$622.4 | -$501.6 | |
| Total cash flows from financing | -$1884 | -$446.4 | -$889.3 | -$585.5 |
| Effect of exchange rate | -$15.3 | -$10.2 | $1.3 | -$0.4 |
| Change in cash and equivalents | $341.6 | -$89.9 | -$439.6 | -$81.8 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1372.3 | $1091.7 | $1129.9 | -$1205.1 |
| Operating activities | ||||
| Depreciation | $923.6 | $938.7 | $843.1 | $812.7 |
| Business acquisitions & disposals | -$180.4 | -$7.2 | -$3923.7 | -$370.8 |
| Stock-based compensation | $95.1 | $87.8 | $89.5 | $82.1 |
| Total cash flows from operations | $2411.8 | $1788.4 | $2061.9 | $1860.2 |
| Investing activities | ||||
| Capital expenditures | -$764.9 | -$710.6 | -$630.8 | -$483.7 |
| Investments | ||||
| Total cash flows from investing | -$990.5 | -$716.8 | -$4579.7 | -$414.5 |
| Financing activities | ||||
| Dividends paid | -$617.3 | -$602.8 | -$566.4 | -$560.8 |
| Sale and purchase of stock | -$13.7 | -$518.2 | -$106.6 | -$146.2 |
| Net borrowings | -$501.9 | $89.7 | $2121.3 | $143.3 |
| Total cash flows from financing | -$1054.7 | -$837.3 | $1603.2 | -$341.8 |
| Effect of exchange rate | -$45.7 | $4.4 | $14.3 | -$30.1 |
| Change in cash and equivalents | $320.9 | $238.7 | -$900.3 | $1073.8 |
News
Fundamentals
| Market cap | $70.85B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 283.20M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.71 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.30 |
| Quick ratio | 0.97 |